KALV icon

KalVista Pharmaceuticals
KALV

Overview Fund Activity

25 hedge funds and large institutions have $61.6M invested in KalVista Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
25
Holders Change
+1
Holders Change %
+4.17%
% of All Funds
0.57%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
5
Increased
4
Reduced
7
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
EAM
Eventide Asset Management
Massachusetts
+$1.81M
2
SLG
Stanley-Laman Group
Pennsylvania
+$429K
3
BCM
Bridgeway Capital Management
Texas
+$389K
4
DZ Bank
DZ Bank
Germany
+$385K
5
DS
DRW Securities
Illinois
+$28.4K

Top Sellers

1
NC
Nexthera Capital
New York
-$1.76M
2
Renaissance Technologies
Renaissance Technologies
New York
-$430K
3
Deutsche Bank
Deutsche Bank
Germany
-$385K
4
Goldman Sachs
Goldman Sachs
New York
-$151K
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$77.3K
Name Holding Trade Value Shares
Change 		Shares
Change %
Goldman Sachs
26
Goldman Sachs
New York
– -$151K -15,528 Closed
Barclays
27
Barclays
United Kingdom
– -$13K -1,349 Closed
CHP
28
Cable Hill Partners
Oregon
– -$11K -1,000 Closed
1
2